Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.01B |
| 2 |
e.l.f. Beauty
ELF
|
+$324M |
| 3 |
DraftKings
DKNG
|
+$263M |
| 4 |
Pinduoduo
PDD
|
+$226M |
| 5 |
Datadog
DDOG
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.68B |
| 2 |
NVIDIA
NVDA
|
+$1.46B |
| 3 |
Spotify
SPOT
|
+$1.03B |
| 4 |
Mercado Libre
MELI
|
+$765M |
| 5 |
Moody's
MCO
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.34% |
| 2 | Technology | 28.05% |
| 3 | Communication Services | 17.02% |
| 4 | Healthcare | 9.5% |
| 5 | Financials | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Calix
CALX
$2.39B
| $464K | ﹤0.01% |
13,308
-1,457
| -10% | -$51.3K |
|
|
BAND
252
Bandwidth Inc
BAND
$1.61B
| $460K | ﹤0.01% |
27,017
-2,966
| -10% | -$55.7K |
|
253
Rexford Industrial Realty
REXR
$8.19B
| $357K | ﹤0.01% |
9,245
-236,431
| -96% | -$10.2M |
|
254
Healthcare Realty
HR
$6.84B
| $333K | ﹤0.01% |
19,628
-18,814
| -49% | -$331K |
|
255
Expensify
EXFY
$245M
| $249K | ﹤0.01% |
74,307
-855,978
| -92% | -$2.3M |
|
256
Cardlytics
CDLX
$21.5M
| $187K | ﹤0.01% |
5,041
-51,699
| -91% | -$1.98M |
|
257
Spire Global
SPIR
$555M
| $187K | ﹤0.01% |
13,259
| – | – |
|
258
Sutro Biopharma
STRO
$421M
| $89.8K | ﹤0.01% |
4,879
-147,055
| -97% | -$4.49M |
|
|
NCNA
259
NuCana
NCNA
$6.12M
| $43.7K | ﹤0.01% |
184
| – | – |
|
260
Teradyne
TER
$59.3B
| $39.3K | ﹤0.01% |
312
+22
| +8% | +$2.6K |
|
261
CRH
CRH
$66.8B
| $35.1K | ﹤0.01% |
379
-12
| -3% | -$1.16K |
|
262
Stantec
STN
$8.39B
| $30.5K | ﹤0.01% |
389
+89
| +30% | +$7.38K |
|
263
Veeva Systems
VEEV
$37.4B
| $23.1K | ﹤0.01% |
110
-15,239
| -99% | -$3.35M |
|
264
Unilever
UL
$136B
| $22.6K | ﹤0.01% |
354
+78
| +28% | +$5.27K |
|
265
Rio Tinto
RIO
$164B
| $18.8K | ﹤0.01% |
319
+37
| +13% | +$2.36K |
|
266
AB InBev
BUD
$165B
| $5.01K | ﹤0.01% |
100
| – | – |
|
|
NVO
267
Novo Nordisk
NVO
$209B
| $4.56K | ﹤0.01% |
53
| – | – |
|
268
TotalEnergies
TTE
$190B
| $3.16K | ﹤0.01% |
+58
| New | +$3.53K |
|
269
Li Auto
LI
$12.7B
| $2.69K | ﹤0.01% |
112
+72
| +180% | +$1.78K |
|
270
Genmab
GMAB
$19.5B
| $1.13K | ﹤0.01% |
54
| – | – |
|
271
Scilex Holding
SCLX
$48.9M
| $223 | ﹤0.01% |
15
| – | – |
|
272
Alector
ALEC
$199M
| – | – |
-78,835
| Closed | -$367K |
|
273
Ascendis Pharma A/S
ASND
$16.8B
| – | – |
-21,403
| Closed | -$3.2M |
|
274
BCE
BCE
$21.2B
| – | – |
-31,257
| Closed | -$1.09M |
|
275
CRISPR Therapeutics
CRSP
$5.17B
| – | – |
-364,768
| Closed | -$17.1M |
|
Similar funds
Baillie Gifford & Co's Q4 2024 Portfolio in Review
As of Q4 2024, Baillie Gifford & Co held 285 positions worth $130B, down 2.6% from $134B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Baillie Gifford & Co withdrew a net $8.81B in Q4 2024, closing 14 positions and reducing 181 holdings. Its most notable exit was Mettler-Toledo International, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in DraftKings worth $247M.
- Baillie Gifford & Co's largest Q4 2024 buy was DraftKings: 6,633,458 shares worth $247M.
- Baillie Gifford & Co added most to Applovin in Q4 2024, an estimated $1.01B increase.
- Baillie Gifford & Co's biggest Q4 2024 reduction was Tesla, cutting an estimated $1.68B.
- Baillie Gifford & Co fully exited Mettler-Toledo International in Q4 2024, selling an estimated $145M.
- Baillie Gifford & Co's ten largest holdings make up 42% of its $130B portfolio in Q4 2024.
- Baillie Gifford & Co opened 8 new positions and closed 14 in Q4 2024.
- Baillie Gifford & Co's portfolio value fell 2.6% quarter-over-quarter to $130B.
Based on Baillie Gifford & Co's 13F filing for Q4 2024, filed 31 Jan 2025.